The ENTR ETF: Once Incurable Maladies Now Within Reach
December 17, 2020 at 06:00 AM EST
The healthcare sector has been solid in 2020, but the truly impressive gains are coming by way of the companies disrupting the industry. Investors looking to access high-flying names such as CRISPR Therapeutics (NASDAQ: CRSP) and Twist Bioscience (NASDAQ: TWST) should consider innovative strategies such as the Entrepreneur 30 Fund ( ENTR ).